
GC36699
EGF816 mesylate
Also listed as Nazartinib mesylate
Nazartinib mesylate (EGF816 mesylate) is a novel, covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0·222 min?1 on EGFR(L858R/790M) mutant, respectively
ChemicalCAS1508250-72-3MW591.12FormulaC27H35ClN6O5S
- CAS number
- 1508250-72-3
- Molecular weight
- 591.12
- Formula
- C27H35ClN6O5S
- Solubility
- Soluble in DMSO
- InChIKey
- BJRYTAMUVASSBY-ZJULCNDBSA-N
- Catalogue number
- GC36699
- Brand
- GLPBIO
Computed properties PubChem CID 91809207 · TPSA 146 Ų · H-bond donors 2 · H-bond acceptors 8
- TPSA
- 146 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 6
- Heavy atoms
- 40
SMILES CC1=NC=CC(=C1)C(=O)NC2=NC3=C(N2[C@@H]4CCCCN(C4)C(=O)/C=C/CN(C)C)C(=CC=C3)Cl.CS(=O)(=O)O
Computed descriptors from PubChem (CID 91809207), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il